Endymed Ltd (TLV: ENDY)
Israel
· Delayed Price · Currency is ILS · Price in ILA282.70
-8.00 (-2.75%)
Dec 18, 2024, 3:44 PM IDT
Endymed Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 18.94 | 22.78 | 21.33 | 21.78 | 14.35 | 16.45 | Upgrade
|
| Revenue Growth (YoY) | -17.00% | 6.77% | -2.06% | 51.85% | -12.78% | -10.88% | Upgrade
|
| Cost of Revenue | 10.29 | 11.23 | 11.39 | 11.72 | 6.81 | 6.68 | Upgrade
|
| Gross Profit | 8.65 | 11.55 | 9.95 | 10.06 | 7.54 | 9.76 | Upgrade
|
| Selling, General & Admin | 7.86 | 7.73 | 5.71 | 4.51 | 5.47 | 5.89 | Upgrade
|
| Research & Development | 2.9 | 2.9 | 2.87 | 2.54 | 1.7 | 1.99 | Upgrade
|
| Operating Expenses | 10.76 | 10.63 | 8.58 | 7.05 | 7.17 | 7.87 | Upgrade
|
| Operating Income | -2.11 | 0.92 | 1.37 | 3.02 | 0.37 | 1.89 | Upgrade
|
| Interest Expense | -0.07 | -0.04 | -0.04 | -0.04 | -0.04 | -0.01 | Upgrade
|
| Interest & Investment Income | 0.21 | 0.22 | 0.08 | 0 | 0.01 | 0.02 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.02 | -0.02 | 0.33 | -0.2 | 0.04 | -0.06 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.03 | -0.03 | -0.03 | -0.13 | -0.21 | -0.09 | Upgrade
|
| EBT Excluding Unusual Items | -2.02 | 1.05 | 1.71 | 2.65 | 0.16 | 1.75 | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.15 | - | Upgrade
|
| Pretax Income | -2.02 | 1.05 | 1.71 | 2.65 | 0.31 | 1.75 | Upgrade
|
| Income Tax Expense | -0.2 | 0.5 | 0.86 | -2.51 | - | - | Upgrade
|
| Net Income | -1.82 | 0.55 | 0.85 | 5.16 | 0.31 | 1.75 | Upgrade
|
| Net Income to Common | -1.82 | 0.55 | 0.85 | 5.16 | 0.31 | 1.75 | Upgrade
|
| Net Income Growth | - | -34.94% | -83.53% | 1575.97% | -82.36% | -13.61% | Upgrade
|
| Shares Outstanding (Basic) | 14 | 14 | 14 | 14 | 14 | 14 | Upgrade
|
| Shares Outstanding (Diluted) | 14 | 14 | 14 | 14 | 14 | 14 | Upgrade
|
| Shares Change (YoY) | -1.66% | -1.57% | 0.64% | 1.47% | - | 23.30% | Upgrade
|
| EPS (Basic) | -0.13 | 0.04 | 0.06 | 0.38 | 0.02 | 0.13 | Upgrade
|
| EPS (Diluted) | -0.13 | 0.04 | 0.06 | 0.37 | 0.02 | 0.13 | Upgrade
|
| EPS Growth | - | -34.43% | -83.51% | 1550.17% | -82.34% | -30.00% | Upgrade
|
| Free Cash Flow | -2.32 | -0.71 | -0.25 | 4.56 | 1.26 | 1.28 | Upgrade
|
| Free Cash Flow Per Share | -0.17 | -0.05 | -0.02 | 0.33 | 0.09 | 0.09 | Upgrade
|
| Gross Margin | 45.67% | 50.71% | 46.62% | 46.20% | 52.53% | 59.36% | Upgrade
|
| Operating Margin | -11.11% | 4.05% | 6.41% | 13.85% | 2.57% | 11.49% | Upgrade
|
| Profit Margin | -9.60% | 2.43% | 3.98% | 23.70% | 2.15% | 10.62% | Upgrade
|
| Free Cash Flow Margin | -12.26% | -3.09% | -1.17% | 20.93% | 8.78% | 7.76% | Upgrade
|
| EBITDA | -1.96 | 1.06 | 1.53 | 3.52 | 0.84 | 2.33 | Upgrade
|
| EBITDA Margin | -10.34% | 4.65% | 7.15% | 16.18% | 5.83% | 14.14% | Upgrade
|
| D&A For EBITDA | 0.15 | 0.14 | 0.16 | 0.51 | 0.47 | 0.44 | Upgrade
|
| EBIT | -2.11 | 0.92 | 1.37 | 3.02 | 0.37 | 1.89 | Upgrade
|
| EBIT Margin | -11.11% | 4.05% | 6.41% | 13.85% | 2.57% | 11.49% | Upgrade
|
| Effective Tax Rate | - | 47.33% | 50.15% | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.